GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Win-Partners Co 3183.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

1,270

+2.75%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Win-Partners Co

Its shares trade on Tokyo Stock Exchange under the ticker 3183.T. It has been listed since 1 April 2013. In the fiscal year to 31 March 2026, it reported revenue of ¥90.39bn and net income of ¥2.12bn. At that date it held total assets of ¥50.63bn and shareholders' equity of ¥23.29bn.

WIN-Partners Co., Ltd. engages in the management of its group of companies that sell medical devices. The company is headquartered in Chuo-Ku, Tokyo-To. The company went IPO on 2013-04-01. The firm is mainly in the provision of medical device, such as catheters used in ischemic heart disease, pacemakers used in cardiac rhythm management area, artificial blood vessels used for cardiovascular surgery area, embolization coil used in peripheral vascular disease and brain surgery, as well as the provision of large -scale medical equipment, such as computed tomography equipment (CT) used in the radiology department and the operating room.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
1 Apr 2013
Employees
609

Leadership

Pay as last reported

  • Mr. Hideumi AkizawaPresident, Chief Executive Officer, President of Subsidiary, Representative Director, since 2013
  • Mr. Hiromi MitagamiExecutive Officer, Senior Director of Sales, Director, since 2013
  • Mr. Keiji MatsumotoExecutive Officer, Chief Director of Administration, Director of General Affairs, Manager of System Development Office, Director, since 2016
  • Mr. Yuji AkitaExecutive Officer, President of Subsidiary, Director, since 2013
  • Mr. Yoichi NakataDirector
  • Mr. Kenjiro IdeIndependent Director
  • Mr. Asaka KandaIndependent Director
  • Mr. Yasuo KikuchiIndependent Director
  • Mr. Shingo MashimaIndependent Director
  • Ms. Etsuko TakamuraIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Win-Partners Co Ltd manages medical device sales with 609 employees in Tokyo-To.
  • The company provides catheters for ischemic heart disease and pacemakers for cardiac rhythm management.
  • Win-Partners offers CT equipment for radiology departments and operating rooms in Japan.

Weaknesses

  • Win-Partners has no presence in the United States market for medical devices.
  • The company's business is limited to Japan's domestic medical device market.
  • Win-Partners does not have a global distribution network for medical equipment.

Opportunities

  • Win-Partners can expand into the U.S. medical device market for catheters and pacemakers.
  • The company could leverage Japan's aging population for increased demand in cardiac devices.
  • Win-Partners may grow by entering the European market for CT equipment sales.

Threats

  • Win-Partners faces competition from global medical device manufacturers in Japan.
  • The company's reliance on Japan's domestic market exposes it to local economic fluctuations.
  • Win-Partners must comply with strict Japanese medical device regulations annually.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.